Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Drug
Shionogi Files NDA for S-217622 COVID-19 Antiviral Drug in China
March 3, 2025
Company
Drug
InnoCare Pharma’s ICP-490 Receives NMPA Approval for Hematological Malignancies
March 3, 2025
Company
Drug
Hrain Biotech and Novartis Receive Breakthrough Therapy Designations for CAR-T and Zolgensma
March 3, 2025
Company
Deals
Techbank Medical Closes RMB 100M Series A to Build Global Innovation Platform
March 3, 2025
Company
Deals
PackGene and Genemagic Partner on AAV Production and CDMO Services
March 3, 2025
Company
Drug
PersonGen BioTherapeutics’ TAA06 Receives Clinical Trial Approval for B7-H3 CAR-T Therapy
March 3, 2025
Company
Drug
Akeso Biopharma’s Cadonilimab Achieves National Delivery in China
March 3, 2025
Company
Drug
Sobi’s Anakinra (Kineret) Prioritized for Review in China for FMF Treatment
March 3, 2025
Company
Drug
Arctic Vision Enrolls First Patient in ARVN003 Phase III Trial for Presbyopia
March 3, 2025
Policy / Regulatory
Guangdong Releases 2022 Non-Immunization Vaccine Catalog (7th Batch)
March 3, 2025
Company
WuXi Biologics’ MFG14 Facility Approved for Microbial Product Manufacturing
March 3, 2025
Company
Drug
JW Therapeutics Initiates Phase I Study of JWATM204 for Hepatocellular Carcinoma
March 3, 2025
1
2
…
1,180
1,181
1,182
1,183
1,184
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?